• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Archives for RTS

GlaxoSmithKline Malaria Vaccine Candidate Results Disappointing

November 9, 2012 By Malaria.com Leave a Comment

The latest clinical trial of the world’s leading malaria vaccine candidate produced disappointing results on Friday. The infants it was given to had only about a third fewer infections than a control group. Three shots of the vaccine, known as RTS, S or Mosquirix and produced by GlaxoSmithKline, gave babies fewer than 12 weeks old 31 percent protection against detectable malaria and 37 percent … [Read more...]

Filed Under: Malaria News Tagged With: GlaxoSmithKline, Malaria Vaccine, Mosquirix, RTS

Malaria Vaccine

May 13, 2012 By Malaria Q&A Leave a Comment

QUESTION What is the shot you get to prevent malaria? ANSWER There is currently no shot available to prevent malaria. The most promising vaccine candidate, called RTS,S and being developed by GlaxoSmithKline, is currently undergoing Phase III trials in children in Africa. Preliminary results have indicated it may prevent up to 50% of malaria cases, though this varies by age group and … [Read more...]

Filed Under: Malaria Q&A Tagged With: GlaxoSmithKline, Phase III clinical trials, RTS, vaccine

Why not create a vaccine for malaria?

March 12, 2012 By Malaria Q&A Leave a Comment

QUESTION Why not create a vaccine for malaria? ANSWER There are many teams of scientists working hard to try to produce a malaria vaccine. In fact, only last year, the preliminary results of a vaccine trial were published. The vaccine, called RTS,S, has been produced by GlaxoSmithKline and is in the midst of Phase III trials in Africa. The preliminary results showed approximately a … [Read more...]

Filed Under: Malaria Q&A Tagged With: Clinical Trials, financial resources, GlaxoSmithKline, Malaria Vaccine Initiative, morbidity, PATH, pharmaceutical companies, RTS, S, severe malaria, vaccine, vaccine testing

Malaria Vaccine Research

March 9, 2012 By Malaria Q&A Leave a Comment

QUESTION Is there any research to produce anti malaria vaccine, if not, why? ANSWER There are many teams of scientists working hard to try to produce a malaria vaccine. In fact, only last year, the preliminary results of a vaccine trial were published. The vaccine, called RTS,S, has been produced by GlaxoSmithKline and is in the midst of Phase III trials in Africa. The preliminary … [Read more...]

Filed Under: Malaria Q&A Tagged With: GlaxoSmithKline, immune response variation, Malaria Control, malaria research, Malaria Vaccine Initiative, PATH, Phase III trial, Plasmodium, RTS, S, strain variation, vaccine

Malaria Vaccine

October 24, 2011 By Malaria Q&A Leave a Comment

QUESTION For how long does this vaccine work? ANSWER There is not yet a commercially available vaccine against malaria. Recently, results were published (in the New England Journal of Medicine - press releases and news reports about the study are available through the main page of www.malaria.com) presenting preliminary findings of the first Phase 3 clinical trial for a vaccine, called … [Read more...]

Filed Under: Malaria Q&A Tagged With: Bednets, Malaria Control, Malaria Vaccine, New England Journal of Medicine, RTS, S clinical trial

The “E” word and the “V” word: Two Holy Grails of Malaria Control

October 24, 2011 By Claire Standley, Editor Leave a Comment

The Roll Back Malaria Partnership talks confidently of elimination—many others question if this is possible without new interventions. The recent publication of the first Phase 3 clinical trial for a malaria vaccine shows promise, but is it actually good enough? REVIEW OF: Roll Back Malaria Partnership, “Eliminating Malaria: Learning from the Past, Looking Ahead”, Progress & … [Read more...]

Filed Under: Blogs Tagged With: malaria elimination, Malaria Vaccine, New England Journal of Medicine, Phase III clinical trials, Roll Back Malaria Partnership, RTS, S Clinical Trials Partnership, The Lancet, UNDP, UNICEF, World Bank, World Health Organisation

GSK and Johnson & Johnson Announce Malaria Vaccine Collaboration

April 6, 2011 By Malaria.com Leave a Comment

GlaxoSmithKline Biologicals (GSK Bio) and Crucell NV (Johnson & Johnson) have announced a collaboration to develop a vaccine approach aimed at boosting the efficacy of the world’s most clinically advanced malaria vaccine candidate, RTS,S. The PATH Malaria Vaccine Initiative (MVI) today congratulated the companies on the partnership. "We are excited by the potential of this new endeavor for … [Read more...]

Filed Under: Malaria News Tagged With: Ad26.CS, Ad35.CS, Ashley Birkett, Christian Loucq, Crucell, GlaxoSmithKline, GSK Bio, Johnson & Johnson, PATH Malaria Vaccine Initiative (MVI), Prime-Boost, RTS

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2023 Malaria.com · Log in